Life Sciences at Goldman Sachs Alternatives

Funding rounds backed by Life Sciences at Goldman Sachs Alternatives.

Export CSV
Funding disclosed in full
$200M
Median round
$200M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
AirNexis Therapeutics

Develops therapeutics for pulmonary diseases, specifically COPD

$200MSeries ABiotechUnited States
6 participantsEnavate SciencesFrazier Life SciencesLife Sciences at Goldman Sachs AlternativesLongitude CapitalOrbiMedSR One